Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BIOCON.NSthis companyBiocon Limited	₹368.50	127.98×	1.45×	2.92×	18.14×	12.2%	34.8%	8.9%	2.3%	1.1%	2.3%	-1.1%	0.45×	3.61×	1.51×	1.22×	0.2%	6	1.63	2	C+
ANTHEM.NSAnthem Biosciences Ltd.	₹958.15	62.21×	12.1×	17.33×	43.89×	-76.6%	42.1%	32.9%	27.9%	19.5%	16.1%	1.9%	0.02×	-0.26×	101.5×	5.54×	0.0%	5	77.36	1	D+
CONCORDBIO.NSConcord Biotech Limited	₹596.80	41.1×	5.32×	10.16×	25.54×	-74.8%	41.9%	27.8%	24.7%	12.9%	10.7%	1.6%	0×	-0.03×	1,034.4×	7.39×	1.0%	3	30.82	3	B+
DCAL.NSDishman Carbogen Amcis Limited	₹167.10	20.9×	0.3×	0.69×	7.34×	-102.0%	25.2%	7.6%	3.3%	1.5%	1.9%	3.8%	0.46×	3.71×	1.28×	1.23×	0.0%	3	—	2	C
FERMENTA.BOFermenta Biotech Ltd.	₹431.00	12.92×	2.28×	1.77×	10.27×	-76.5%	43.4%	14.6%	13.7%	17.7%	10.4%	6.0%	0.28×	0.83×	6.63×	1.86×	0.8%	3	—	3	B
KOBO.BOKobo Biotech Ltd.	₹3.56	-1.92×	-0.07×	0×	-173.79×	-1982.9%	0.0%	0.0%	0.0%	3.7%	-2.1%	2.1%	-1.05×	-162.73×	-2,480×	0.23×	0.0%	3	—	—	—
Peer median	—	20.9×	2.28×	1.77×	10.27×	-76.6%	41.9%	14.6%	13.7%	12.9%	10.4%	2.1%	0.02×	-0.03×	6.63×	1.86×	0.0%	3	54.09	3	—